PrescriptionGiant is a FREE prescription savings program that can save you up to 75% on your prescriptions with or without insurance!

Tzield (Generic Teplizumab-mzwv injection)

Actual product appearance may differ slightly.

Click the CARD below to print or take a screenshot on your mobile phone or tablet. There is no need to download another app!

If you would like to personalize your card enter your full name in the member name field below the card at this link and click the Update button.

Why is this medication prescribed?

Teplizumab-mzwv injection is prescribed for the prevention of type 1 diabetes in individuals at risk of developing the condition. Type 1 diabetes is an autoimmune disease where the body’s immune system attacks insulin-producing cells in the pancreas, leading to insulin deficiency. Teplizumab-mzwv is a monoclonal antibody that works by modulating the immune response, potentially slowing down or halting the destruction of pancreatic beta cells.

How should this medicine be used?

Teplizumab-mzwv injection is typically used under the guidance and supervision of a healthcare professional, such as a doctor or nurse. The specific dosage and administration regimen can vary depending on factors such as the individual’s age, weight, medical history, and the condition being treated. Here are general guidelines for the use of Teplizumab-mzwv injection:

  • Administration: Teplizumab-mzwv is administered as an intravenous infusion, which means it is injected directly into a vein. The injection is typically given over a specified period of time, often ranging from 30 minutes to several hours, depending on the dosage and infusion rate determined by the healthcare provider.
  • Preparation: The healthcare provider will prepare the Teplizumab-mzwv injection according to the manufacturer’s instructions. This may involve diluting the medication with a compatible infusion solution before administering it to the patient.
  • Monitoring: During the infusion, the patient will be closely monitored by healthcare staff for any signs of adverse reactions or side effects. Vital signs such as blood pressure, heart rate, and temperature may be monitored regularly throughout the infusion process.
  • Frequency: The frequency of Teplizumab-mzwv injections can vary depending on the specific treatment regimen prescribed by the healthcare provider. Some individuals may receive a single infusion, while others may require multiple infusions spaced out over a period of time.
  • Follow-up: After receiving Teplizumab-mzwv injection, patients will typically be monitored for a period of time to assess their response to treatment and monitor for any potential side effects. Follow-up appointments with the healthcare provider may be scheduled to evaluate the effectiveness of the treatment and adjust the treatment plan as needed.

It’s essential for patients to follow their healthcare provider’s instructions carefully regarding the administration of Teplizumab-mzwv injection and attend all scheduled appointments for monitoring and follow-up. Additionally, patients should report any unusual or concerning symptoms to their healthcare provider promptly.

Other uses for this medicine

Teplizumab-mzwv injection is primarily used for the prevention of type 1 diabetes in individuals at risk of developing the condition. However, as with many medications, there may be other potential uses for Teplizumab-mzwv that are being explored in clinical trials or off-label use. It’s essential to consult with a healthcare professional to determine the appropriate use of Teplizumab-mzwv and to ensure that any potential risks and benefits are carefully considered.

What special precautions should I follow?

As for special precautions to follow when using Teplizumab-mzwv injection, it’s important to note the following:

  • Administration by Healthcare Professionals: Teplizumab-mzwv injection should be administered by trained healthcare professionals in a clinical setting where appropriate monitoring and management of potential adverse reactions are available.
  • Allergic Reactions: Patients should be monitored for signs of allergic reactions during and after administration of Teplizumab-mzwv. These reactions can include symptoms such as rash, itching, swelling, difficulty breathing, or anaphylaxis. Individuals with known hypersensitivity to Teplizumab-mzwv or any of its components should not receive the medication.
  • Infections: Teplizumab-mzwv may increase the risk of infections, including bacterial, viral, or fungal infections. Patients should be monitored for signs and symptoms of infection, and appropriate treatment should be initiated promptly if an infection occurs.
  • Immunosuppression: Teplizumab-mzwv works by modulating the immune response, which can result in immunosuppression. Patients receiving Teplizumab-mzwv may be at increased risk of opportunistic infections or reactivation of latent infections. Close monitoring for signs of infection is essential, and patients should avoid close contact with individuals who have active infections.
  • Pregnancy and Breastfeeding: The safety of Teplizumab-mzwv during pregnancy and breastfeeding has not been established. Pregnant or breastfeeding individuals should discuss the potential risks and benefits of Teplizumab-mzwv with their healthcare provider before initiating treatment.
  • Monitoring and Follow-up: Patients receiving Teplizumab-mzwv should be closely monitored for adverse reactions and should attend all scheduled follow-up appointments with their healthcare provider to assess treatment response and monitor for any potential complications.

It’s important for patients to discuss any concerns or questions about Teplizumab-mzwv injection with their healthcare provider before starting treatment. Additionally, they should inform their healthcare provider about any other medications, supplements, or medical conditions they have before receiving Teplizumab-mzwv to avoid potential drug interactions or complications.

What special dietary instructions should I follow?

As for special dietary instructions, there are no specific dietary restrictions associated with teprotumumab-trbw injection. However, it’s always advisable to maintain a balanced and healthy diet to support overall health and well-being during treatment.

What should I do if I forget a dose?

If you forget a dose of teprotumumab-trbw injection, contact your healthcare provider as soon as possible for guidance. They will advise you on the appropriate course of action, which may involve rescheduling the missed dose or adjusting the treatment plan as necessary. Do not attempt to administer extra doses to make up for a missed one without consulting your healthcare provider first.

What side effects can this medication cause?

Teplizumab-mzwv injection, like any medication, can potentially cause side effects. While not everyone will experience these side effects, it’s essential to be aware of them. Common side effects of Teplizumab-mzwv injection may include:

  • Infusion-related reactions: These can occur during or shortly after the infusion and may include symptoms such as fever, chills, nausea, vomiting, headache, dizziness, fatigue, rash, itching, or difficulty breathing. Healthcare providers typically monitor patients closely during the infusion to manage these reactions promptly.
  • Infections: Teplizumab-mzwv may increase the risk of infections, including respiratory infections, urinary tract infections, and viral infections. Patients should be vigilant for symptoms of infection and report them to their healthcare provider promptly.
  • Hypersensitivity reactions: Some individuals may experience allergic reactions to Teplizumab-mzwv, which can range from mild (e.g., rash, itching) to severe (e.g., anaphylaxis). Patients with known hypersensitivity to Teplizumab-mzwv or any of its components should not receive the medication.
  • Immunosuppression: Teplizumab-mzwv works by modulating the immune response, which can lead to immunosuppression. This may increase the risk of opportunistic infections or reactivation of latent infections.
  • Liver enzyme abnormalities: Some patients may experience elevated liver enzymes (alanine aminotransferase, aspartate aminotransferase) while receiving Teplizumab-mzwv. These abnormalities are typically detected through routine blood tests and may require further evaluation.
  • Decreased lymphocyte count: Teplizumab-mzwv may cause a decrease in lymphocyte count, which can increase the risk of infections. Monitoring of blood cell counts may be necessary during treatment.
  • Other side effects: Less common side effects of Teplizumab-mzwv may include diarrhea, abdominal pain, muscle or joint pain, and changes in blood pressure.

It’s important for patients to report any side effects or concerns to their healthcare provider promptly. Additionally, patients should follow all instructions provided by their healthcare provider for monitoring and management of side effects during treatment with Teplizumab-mzwv.

What should I know about storage and disposal of this medication?

Storage and disposal of Teprotumumab-trbw Injection:

  • Storage: Store Teprotumumab-trbw Injection in the refrigerator at a temperature of 2°C to 8°C (36°F to 46°F). Do not freeze. Protect the medication from light. Do not shake the vial. Keep it in its original carton until ready to use to protect it from light.
  • Disposal: Dispose of unused or expired Teprotumumab-trbw Injection according to local regulations. Do not dispose of it in household trash or flush it down the toilet unless instructed to do so. Consult with your healthcare provider or pharmacist for proper disposal methods.

In case of emergency/overdose

In case of emergency/overdose of Teprotumumab-trbw Injection:

  • Seek Medical Attention: If you suspect an overdose or experience severe adverse effects after receiving Teprotumumab-trbw Injection, seek immediate medical attention. Contact your healthcare provider, local emergency services, or go to the nearest emergency room.
  • Symptom Management: While waiting for medical assistance, follow any specific instructions provided by your healthcare provider. If possible, provide information about the medication, dosage, and timing of administration.

What other information should I know?

  • Monitoring: Your healthcare provider will closely monitor your condition and response to treatment while receiving Teprotumumab-trbw Injection. This may involve regular check-ups, physical examinations, and laboratory tests.
  • Adverse Effects: Be aware of potential side effects of Teprotumumab-trbw Injection, including infusion reactions, infections, allergic reactions, and changes in liver or kidney function. Report any adverse effects to your healthcare provider promptly.
  • Follow-up: Attend all scheduled appointments with your healthcare provider to ensure proper monitoring and management of your condition. Inform your healthcare provider of any changes in your health status or medication regimen.
  • Medication Interactions: Inform your healthcare provider about all medications, supplements, and herbal products you are taking, as they may interact with Teprotumumab-trbw Injection. Your healthcare provider will assess potential interactions and adjust your treatment plan accordingly.
  • Patient Education: Understand the purpose of Teprotumumab-trbw Injection, how it is administered, potential side effects, and the importance of adherence to the prescribed treatment plan. Ask your healthcare provider any questions or concerns you may have about the medication.
Copyright © 2023